Stanowisko Sekcji Immunoterapii Polskiego Towarzystwa Alergologicznego w sprawie prowadzenia alergenowo swoistej immunoterapii (AIT) u pacjentów zagrożonych wystąpieniem lub z rozpoznanymi chorobami na tle autoimmunizacji

Allergen immunotherapy (AIT) in patients with airborne allergy is crucial as the only therapeutic approach of causal treatment. For this reason, establishing contradictions for this treatment remain key issue in many patients. The currently understood AIT mechanisms unambiguously point to the fact that it affects the immune system on the regulatory level. For this reason, we should consider its possible effect on the course of the disease in patients with concomitant immune diseases and especially autoimmune diseases. The presented position paper expresses expert's opinion on establishing contradiction for allergen immunotherapy in in five separate groups of patients with autoimmune disorders.